{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:14:48Z","timestamp":1792610088221,"version":"4.5.0"},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>It remains unclear to what extent the brain is affected by Maroteaux\u2010Lamy syndrome (MPS VI), a progressive lysosomal storage disorder. While enzyme replacement therapy (ERT) elicits positive effects, the drug cannot cross the blood\u2013brain barrier. We therefore studied cognitive development and brain abnormalities in the Dutch MPS VI patient population treated with ERT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a series of 11 children with MPS VI (age 2 to 20 years), we assessed cognitive functioning and brain magnetic resonance imaging prospectively at the start of ERT and at regular times thereafter up to 4.8 years. We also assessed the children's clinical characteristics, their siblings\u2019 cognitive development, and their parents\u2019 educational levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The patients\u2019 intelligence scores ranged from normal to mentally delayed (range test scores 52\u2013131). In 90 %, their scores remained fairly stable during follow\u2010up, generally lying in the same range as their siblings\u2019 test scores (median for patients\u2009=\u2009104, median for siblings\u2009=\u200988) and comparing well with the parental educational levels. Native\u2010speaking patients had higher intelligence test scores than non\u2010native\u2010speaking patients. Two patients, both with high baseline glycosaminoglycan levels in their urine and severe mutations in the arylsulfatase B gene, scored clearly lower than expected. Patients with pY210C performed best. Brain abnormalities were aspecific, occurring more in patients with severe symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study shows that cognitive development in MPS VI patients is determined not only by familial and social\u2010background factors, but, in patients with a severe form of the disease, also by the disease itself. Therefore in patients with severe disease presentation cognition should be monitored carefully.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s10545-015-9895-8","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T12:45:39Z","timestamp":1444308339000},"page":"285-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long\u2010term cognitive follow\u2010up in children treated for Maroteaux\u2010Lamy syndrome"],"prefix":"10.1002","volume":"39","author":[{"given":"Berendine J.","family":"Ebbink","sequence":"first","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases, Department of Pediatrics Erasmus MC University Medical Center \u2014 Sophia Children's Hospital P.O. Box 2060 Rotterdam 3000 CB The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion M. G.","family":"Brands","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases, Department of Pediatrics Erasmus MC University Medical Center \u2014 Sophia Children's Hospital P.O. Box 2060 Rotterdam 3000 CB The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M. P.","family":"den van Hout","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases, Department of Pediatrics Erasmus MC University Medical Center \u2014 Sophia Children's Hospital P.O. Box 2060 Rotterdam 3000 CB The Netherlands"},{"name":"Department of Pediatric Neurology Erasmus University Medical Center \u2014 Sophia Children's Hospital Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten H.","family":"Lequin","sequence":"additional","affiliation":[{"name":"Department of Radiology Erasmus University Medical Center Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R. J. Coebergh","family":"den van Braak","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Erasmus University Medical Center \u2014 Sophia Children's Hospital Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne L.","family":"van de Weitgraven","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases, Department of Pediatrics Erasmus MC University Medical Center \u2014 Sophia Children's Hospital P.O. Box 2060 Rotterdam 3000 CB The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Plug","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases, Department of Pediatrics Erasmus MC University Medical Center \u2014 Sophia Children's Hospital P.O. Box 2060 Rotterdam 3000 CB The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke K.","family":"Aarsen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology Erasmus University Medical Center \u2014 Sophia Children's Hospital Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases, Department of Pediatrics Erasmus MC University Medical Center \u2014 Sophia Children's Hospital P.O. Box 2060 Rotterdam 3000 CB The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2004.00277.x"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9559-x"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2013.07.016"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7195071"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.psych.53.100901.135233"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-51"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2013.02.013"},{"key":"e_1_2_10_9_1","first-page":"89","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: growth and pubertal development in patients treated with recombinant human N\u2010acetylgalactosamine 4\u2010sulfatase","volume":"3","author":"Decker C","year":"2010","journal-title":"J Pediatr Rehabil Med"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.20515"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1253412"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-2184"},{"key":"e_1_2_10_13_1","volume-title":"The abilities of young children","author":"Griffiths R","year":"1984"},{"key":"e_1_2_10_14_1","volume-title":"The abilities of babies","author":"Griffiths R","year":"1986"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.04.001"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-009-9007-8"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000070874"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20534"},{"key":"e_1_2_10_19_1","volume-title":"Wechsler intelligence scales for children","author":"Kort WSM","year":"2005"},{"key":"e_1_2_10_20_1","first-page":"1285","article-title":"The mucopolysaccharidoses: characterization by cranial MR imaging","volume":"14","author":"Lee C","year":"1993","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_2_10_21_1","volume-title":"Neuropsychological assessment","author":"Lezak MDHD","year":"2012"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9317-5"},{"key":"e_1_2_10_23_1","first-page":"3421","volume-title":"The metabolic and molecular bases of inherited disease","author":"Neufeld EF","year":"2001"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-013-0246-8"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/59197814"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1098"},{"key":"e_1_2_10_27_1","first-page":"337","article-title":"Mucopolysaccharidosis VI (Maroteaux\u2010Lamy's disease)","volume":"25","author":"Spranger JW","year":"1970","journal-title":"Helv Paediatr Acta"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1973.02110190597003"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.30579"},{"key":"e_1_2_10_30_1","volume-title":"SON\u2010R 2 1\/2\u20107: Snijders Oomen non\u2010verbal intelligence test Revised","author":"Tellegen PJWM","year":"2008"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200104000-00031"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-5"},{"key":"e_1_2_10_33_1","volume-title":"Bayley scales of infant development Dutch version","author":"Meulen BFRS","year":"2002"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000269782.80107.fe"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1987.tb02779.x"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2832"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-015-9895-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T03:50:42Z","timestamp":1694749842000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-015-9895-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1007\/s10545-015-9895-8"],"URL":"https:\/\/doi.org\/10.1007\/s10545-015-9895-8","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]}}}